Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?

Sung Kim, Dirk F. Moore, Weichung Shih, Yong Lin, Hui Li, Yu Hsuan Shao, Shunhua Shen, Grace L. Lu-Yao

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95% CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95% CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.

Original languageEnglish
Pages (from-to)116-121
Number of pages6
JournalJournal of Urology
Volume189
Issue number1
DOIs
Publication statusPublished - Jan 2013
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Radiotherapy
Odds Ratio
Observation
Pathologic Constriction
Transurethral Resection of Prostate
Preexisting Condition Coverage
Medicare
Epidemiology
Cohort Studies
Therapeutics
Radiation
Incidence
Population

Keywords

  • prostate
  • prostatic neoplasms
  • radiotherapy
  • SEER program
  • toxicity

ASJC Scopus subject areas

  • Urology

Cite this

Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last? / Kim, Sung; Moore, Dirk F.; Shih, Weichung; Lin, Yong; Li, Hui; Shao, Yu Hsuan; Shen, Shunhua; Lu-Yao, Grace L.

In: Journal of Urology, Vol. 189, No. 1, 01.2013, p. 116-121.

Research output: Contribution to journalArticle

Kim, Sung ; Moore, Dirk F. ; Shih, Weichung ; Lin, Yong ; Li, Hui ; Shao, Yu Hsuan ; Shen, Shunhua ; Lu-Yao, Grace L. / Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?. In: Journal of Urology. 2013 ; Vol. 189, No. 1. pp. 116-121.
@article{53826ed9fc8449279882913ff0e34c48,
title = "Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?",
abstract = "Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95{\%} CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95{\%} CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.",
keywords = "prostate, prostatic neoplasms, radiotherapy, SEER program, toxicity",
author = "Sung Kim and Moore, {Dirk F.} and Weichung Shih and Yong Lin and Hui Li and Shao, {Yu Hsuan} and Shunhua Shen and Lu-Yao, {Grace L.}",
year = "2013",
month = "1",
doi = "10.1016/j.juro.2012.08.091",
language = "English",
volume = "189",
pages = "116--121",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?

AU - Kim, Sung

AU - Moore, Dirk F.

AU - Shih, Weichung

AU - Lin, Yong

AU - Li, Hui

AU - Shao, Yu Hsuan

AU - Shen, Shunhua

AU - Lu-Yao, Grace L.

PY - 2013/1

Y1 - 2013/1

N2 - Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95% CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95% CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.

AB - Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95% CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95% CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.

KW - prostate

KW - prostatic neoplasms

KW - radiotherapy

KW - SEER program

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=84870949940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870949940&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.08.091

DO - 10.1016/j.juro.2012.08.091

M3 - Article

VL - 189

SP - 116

EP - 121

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -